K902571

Substantially Equivalent

MODIFICATION OF SEROCARD RUBELLA IGG TEST

Applicant: Disease Detection International, Inc.
Product code: LFX
Advisory panel: Microbiology
Date received: 1990-06-07
Decision date: 1990-09-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Irvine, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.